EU pharma getting better at meeting PIP deadlines
This article was originally published in SRA
Executive Summary
Pharmaceutical companies did better at complying with EU deadlines for submitting paediatric investigation plans (PIPs) and waiver applications in 2012 compared with their performance the previous year1.